Freising, Bavaria, Germany
With around 254 million people suffering from chronic HBV in 2022 and an estimated 1.2 million deaths annually, HBV represents a major global health problem (WHO 2024). In view of this challenge, I am working on immunotherapy with a focus on multispecific T cell engager antibodies at the Institute of Virology at TUM, headed by Prof. Ulrike Protzer. As part of my research and to encourage collaboration with colleagues in this field, I would be happy to get in contact with you.
Title: "Characterization of a mosaic core antigen of HBV"
Research assistant for a project of a doctoral researcher at the Chair of Zoology headed by Prof. Dr. Harald Luksch with the topic cognitive spatial orientation in chickens (Gallus gallus)
Title: "Properties of the multi-modular glycoside hydrolase Axh43A from Thermoclostridium stercorarium"
Tutoring for the mathematics lecture for first semester students